166 results
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
restrictions from shares previously delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
or other Extensions of Credit to the Credit Parties during the Forbearance Period, subject to satisfaction of the conditions thereto set forth … effective upon the satisfaction (or waiver in writing by Administrative Agent, on behalf of the Required Lenders) of the following conditions precedent
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
for a performance-based incentive equal to $8,000,000 (the “Performance-Based Incentive”), subject to the satisfaction of the Share price performance
8-K
w58oj1b25tj
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
EX-10.1
qaqt8z81p1oz
2 Oct 23
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
7:49am
S-8
EX-4.4
h2z223
5 Jun 23
Registration of securities for employees
5:31pm
424B5
ynrek ufngj8
18 May 23
Prospectus supplement for primary offering
7:45am
8-K
EX-10.1
os1mw6q
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
8-K
EX-10.2
pz9c84
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
DEFR14A
8x41d 53z
24 Apr 23
Revised proxy
9:32am
8-K
EX-99.1
5mdyal wz
26 Sep 22
Completion of Acquisition or Disposition of Assets
5:05pm